BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, June 27, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Regulatory actions for July 7, 2022

July 7, 2022
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ascletis, Biogen, Chinook, Coherus, Junshi, Inflarx, Kazia, Olix, Pyramid, Roche, Sensorion, Takeda,  Titan, Turnstone.
Read More

Other news to note for July 7, 2022

July 7, 2022
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Gnubiotics, Homology, Immunome, Intravacc, Kalvista, Kamada, Mnemo, Pfizer, Plakous, Ring, Roivant, Sollievo, Touchlight, Turnstone, Vast, Walden.
Read More

In the clinic for July 7, 2022

July 7, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Albireo, Aqualung, Cend, Clairvoyant, Enlivex, Humanigen, Inmagene, Innocoll, JW, Kiora, Nordic Nanovector, Obi, Quoin, Sarepta, Vera, Veru.
Read More
COVID-19 research illustration

UK’s Oxford launches pandemic institute to prepare for future threats

July 6, 2022
By Nuala Moran
Oxford University has opened the doors to its new Pandemic Sciences Institute, a £100 million (US$119.5 million) initiative to build on the research and experience of COVID-19, to counter future pandemic threats.
Read More

Regulatory actions for July 6, 2022

July 6, 2022
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Amylyx, Aneurotech, Dyne, Hyloris, Novavax, Pfizer, Sanofi, Xbrane.
Read More

Other news to note for July 6, 2022

July 6, 2022
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Advanz, AM-Pharma, Astellas, Avadel, Beigene, Betterlife, C4X, Codiak, Crescendo, Danuo, Delsitech, Editforce, Elicio, Enosi, Iggenix, Innorna, Intercept, Iveric, Mitsubishi Tanabe, Mogrify, Pierre Fabre, Poxel, Precigen, Sanofi, Sinovac, Stallergenes, Urovant.
Read More
Cross section of brain

Postmortem brain study gives clues to long COVID

July 6, 2022
By Anette Breindl
SARS-CoV-2 infection caused damage to brain blood vessels via a cascade of immune system reactions that was most likely initiated by antibody-dependent cytotoxicity, researchers from the National Institute of Neurological Disorders and Stroke reported in the July 5, 2022, online issue of Brain.
Read More

Curevac files patent suit against Biontech

July 5, 2022
By Cormac Sheridan
Curevac NV has filed a patent lawsuit against fellow German mRNA pioneer Biontech SE claiming that the latter firm’s COVID-19 vaccine, Comirnaty, infringes its intellectual property.
Read More

South Korea approves first homegrown COVID vaccine

July 5, 2022
By Tamra Sami
South Korea’s Ministry of Food and Drug Safety has granted marketing authorization to SK Bioscience Ltd.’s COVID-19 vaccine, Skycovione (GB-510), marking the country’s first homegrown COVID-19 vaccine to be approved. The company has already signed an advanced purchase agreement with the Korea Centers for Disease Control for 10 million doses of the vaccine.
Read More

Japan to create centralized pandemic response agency akin to the US CDC

July 5, 2022
By Tamra Sami
Japan is establishing a centralized infectious disease crisis management agency that will be under direct control of the prime minister. One of the goals is to better clarify the chain of command and to bring together resources and COVID-19 task forces from the Cabinet Secretariat and the Ministry of Health, Labor and Welfare.
Read More
Previous 1 2 … 94 95 96 97 98 99 100 101 102 … 553 554 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 26, 2026.
  • Blue brain with computer chip

    Have brain-computer interfaces finally arrived?

    BioWorld
    More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 23, 2026
  • Cortec Brain Interchange BCI system

    Brain-computer interfaces are here but long road ahead

    BioWorld
    The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
  • Patient using Neuracle NEO system

    2026 marks critical turning point for BCI technology

    BioWorld
    Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing